100 Years Of Respiratory Medi... Health Article

References

1 Ewig S., Seifert K., Kleinfeld T.. Management of patients with community-acquired pneumonia in a primary care hospital: a critical evaluation Respir Med 94 2002 556 563
2 Woodhead M.A., Macfarlane J.T., McCracken J.S., Rose D.H., Finch R.G.. Prospective study of the aetiology and outcome of pneumonia in the community Lancet 1 1987 671 674
3 Viegi G., Pistelli R., Cazzola M.. Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy Respir Med 100 2006 46 55
4 Hoare Z., Lim W.S.. Pneumonia: update on diagnosis and management Br Med J 332 2006 1077 1079
5 Oswald N.C., Simon G., Shooter R.A.. Pneumonia in hospital practice Br J Dis Chest 55 1961 109 118
6 Farr B.M., Bartlett C.L., Wadsworth J., Miller D.L.. Risk factors for community-acquired pneumonia diagnosed upon hospital admission Respir Med 94 2000 954 963
7 Taylor A.B.. The management of respiratory infection Br J Dis Chest 54 1960 157 159
8 Wingfield A.L.. The changing pattern of pneumonia Br J Tuberc Dis Chest 45 1951 27 31
9 MacFarlane J.. Community-acquired pneumonia Br J Dis Chest 81 1987 116 127
10 White R., Dilworth P.. Pneumonia in hospital Br J Dis Chest 82 1988 121 126
11 Pozniak A.L., Swinburn C.R., Johnson N.. Management of AIDS pneumonia Br J Dis Chest 79 1985 105 114
12 Michetti G., Pugliese C., Bamberga M., Ori B.M.. Community-acquired pneumonia: is there a difference in etiology between hospitalized and out-patients? Minerva Med 86 1995 341 351
13 Ewig S., Torres A., Ángeles Marcos M., Angrill J.. Factors associated with unknown aetiology in patients with community-acquired pneumonia Eur Respir J 20 2002 1254 1262
14 Bath J.C., Boussard G.P., Calder M.A., Moffat A.J.. Pneumonia in hospital practice in Edinburgh 1960–1962 Br J Dis Chest 58 1964 1 16
15 Macfarlane J., Holmes W., Gard P., Macfarlane R.. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community Thorax 56 2000 109 114
16 Almirall J., Bolibar I., Vidal J., Sauca G.. Epidemiology of community-acquired pneumonia in adults: a population-based study Eur Respir J 15 2000 757 763
17 Bochud P.Y., Moser F., Enrad P.. Community-acquired pneumonia. A prospective outpatient study Medicine 80 2001 75 87
18 Jokinen C., Heiskanen L., Juvonen H., Kallinen S.. Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland Clin Infect Dis 32 2001 1141 1154
19 Lagerström F., Bader M., Foldevi M., Fredlund H.. Microbiological etiology in clinically diagnosed community-acquired pneumonia in primary care in Örebro, Sweden Clin Microbiol Infect 9 2003 645 652
20 Marrie T.J., Poulin-Costello M., Beecroft M.D., Herman-Gnjidic Z.. Etiology of community-acquired pneumonia treated in an ambulatory setting Respir Med 99 2005 60 65
21 File T.M.. Community-acquired pneumonia Lancet 362 2003 1991 2001
22 de Roux A., Marcos M.A., Garcia E., Mensa J.. Viral community-acquired pneumonia in nonimmunocompromised adults Chest 125 2004 1343 1351
23 Falsey A.R., Erdman D., Anderson L.J., Walsh E.E.. Human metapneumovirus infections in young and elderly adults J Infect Dis 187 2003 785 790
24 Marrie T.J., Peeling R.W., Fine M.J., Singer D.E.. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course Am J Med 101 1996 508 515
25 Jones R.N., Croco M.A., Kugler K.C., Pfaller M.A., Beach M.L.. Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) Diagn Microbiol Infect Dis 37 2000 115 125
26 Logroscino C.D., Penza O., Locicero S., Losito G.. Community-acquired pneumonia in adults: a multicentric observational AIPO study Monaldi Arch Chest Dis 54 1999 11 17
27 Sopena N., Sabria M., Pedro-Botet M.L., Manterola J.M., Socan M., Marinic-Fiser N.. Microbial aetiology of community-acquired pneumonia in hospitalised patients Eur J Clin Microbiol Infect Dis 18 1999 777 782
28 Ruiz-Gonzalez A., Falguera M., Nogues A., Rubio-Caballero M.. Is the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia Am J Med 106 1999 385 390
29 Banks R.A., George R.C., McNicol M.W.. Pneumococcal pneumonia with bacteraemia Br J Dis Chest 78 1984 352 357
30 Isaacs R.D.. Necrotizing pneumonia in bacteraemic pneumococcal infection Br J Dis Chest 80 1986 295 296
31 Blasi F., Cosentini R., Raccanelli R., Rinaldi A.. Emerging pathogens of community-acquired pneumonia: a two-year prospective study J Chemother 7 Suppl. 4 1995 115 116
32 Schneeberger P.M., Dorigo-Zestma J.W., van der Zee A., van Bon M., van Opstal J.L.. Diagnosis of atypical pathogens in patients hospitalized with community-acquired respiratory infection Scan J Infect Dis 36 4 2004 269 273
33 Stout J.E., Yu V.L.. Legionellosis N Engl J Med 337 1997 682 687
34 Feldman C., Ross S., Goolam Mohamed A.. The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy Respir Med 89 1995 187 192
35 Rello J., Bodi M., Mariscal D., Navarro M.. Microbiological testing and outcome of patients with severe community-acquired pneumonia Chest 123 2003 174 180
36 Gowardman J., Trent L.. Severe community acquired pneumonia: a one-year analysis in a tertiary referral intensive care unit N Z Med J 113 2000 161 164
37 El Solh A.A., Sikka P., Ramadan F., Davies J.. Etiology of severe pneumonia in the very elderly Am J Respir Crit Care Med 163 2001 645 651
38 Vergis E.N., Yu V.L.. New directions for future studies of community-acquired pneumonia: optimizing impact on patient care Eur J Clin Microbiol Infect Dis 18 1999 847 851
39 Garau J., Gomez L.. Pseudomonas aeruginosa pneumonia Curr Opin Infect Dis 16 2 2003 135 143
40 Leroy O., Vandenbussche C., Coffinier C., Bosquet C.. Community-acquired aspiration pneumonia in intensive care units. Epidemiological and prognosis data Am J Respir Crit Care Med 156 1997 1922 1929
41 El Solh A.A., Aquilina A.T., Dhillon R.S., Ramadan F., Nowak P., Davies J.. Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia Am J Respir Crit Care Med 166 2002 1038 1043
42 de Roux A., Ewig S., Garcia E.. Mixed community-acquired pneumonia in hospitalised patients Eur Respir J 27 2006 795 800
43 Gutiérrez F., Masiá M., Rodriguez J.C.. Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome Eur J Clin Microbiol Infect Dis 24 2005 377 383
44 Waterer G.W.. Monotherapy versus combination antimicrobial therapy for pneumococcal pneumonia Curr Opin Infect Dis 18 2005 157 163
45 Treanor J.J., Hayden F.G., Vrooman P.S.. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group JAMA 283 2000 1016 1024
46 Nordin J., Mullooly J., Poblete S.. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons aged 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans J Infect Dis 184 2001 665 670
47 Theerthakarai R., El-Halees W., Ismail M., Solis R.A., Khan M.A.. Non value of the initial microbiological studies in the management of non severe community-acquired pneumonia Chest 119 2001 181 184
48 Wunderink R.G., Waterer G.W.. Appropriate microbiological testing in community-acquired pneumonia Chest 119 2001 5 7
49 Leroy O., Santre C., Beuscart C., Georges H.. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an ICU Intensive Care Med 21 1995 24 31
50 Bartlett J.C.. Decline in microbial studies for patients with pulmonary infections Clin Infect Dis 39 2004 170 172
51 Bartlett J.G., Dowell S.F., Mandell L.A., File T.M.. Practice guidelines for the management of community-acquired pneumonia in adults Clin Infect Dis 31 2000 347 382
52 Meehan T.P., Fine M.J., Krumholz H.M.. Quality of care, process, and outcomes in elderly patients with pneumonia JAMA 278 1997 2080 2084
53 Houck P.M., Bratzler D.W., Nsa W.. Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia Arch Intern Med 164 2004 637 644
54 Mandell L.A., Bartlett J.G., Dowell S.F., File T.M., Musher D.M.. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults Clin Infect Dis 37 2003 1405 1433
55 British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults Thorax 56 Suppl 4 2001 1 64
56 Niederman M.S., Mandell L.A., Anzueto A.. Guidelines for the management of adults with community-acquired pneumomia (American Thoracic Society) Am J Respir Crit Care Med 163 2001 1730 1754
57 Woodhead M., Blasi F., Ewig S.. Guidelines for the management of lower respiratory tract infections Eur Respir J 26 2005 1138 1180
58 Skerrett S.J.. Diagnostic testing for community-acquired pneumonia Clin Chest Med 20 1999 531 548
59 Glerant J.C., Hellmuth D., Scmit J.L., Ducroix J.P., Jounieaux V.. Utility of blood cultures in community-acquired pneumonia requiring hospitilization: influence of antibiotic treatment before admission Respir Med 93 1999 208 212
60 Metersky M.L., Ma A., Bratzler D.W., Houck P.M.. Predicting bacteremia in patients with community-acquired pneumonia Am J Respir Crit Care Med 169 2004 342 347
61 Roson B., Carratala J., Verdaguer R., Dorca J., Manresa F., Gudiol F.. Prospective study of the usefulness of sputum Gram stain in the initial approach to community acquired pneumonia requiring hospitalization Clin Infect Dis 31 2000 869 874
62 Musher D.M., Montoya R., Wanahita A.. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia Clin Infect Dis 39 2004 165 169
63 Gutierrez F., Rodriguez J.C., Ayelo A.. Evaluation of the immunochromatographic Binax NOW assay for detection of urinary antigen in a prospective study of community-acquired pneumonia in Spain Clin Infect Dis 36 2003 286 292
64 Murdoch D.R.. Diagnosis of Legionella infection Clin Infect Dis 36 2003 64 69
65 Andreo F., Dominguez J., Ruiz J.. Impact of urine antigen tests to determine the etiology of community-acquired pneumonia in adults Respir Med 100 2006 884 891
66 Smith P.R.. What diagnostic tests are needed for community acquired pneumonia Med Clin North Am 2001 1381 1395
67 Marquette C.H., Wallet F., Nevière R.. Usefulness of direct examination of protected brush specimen in the diagnosis of pneumonia in ventilated patients Eur Respir J 7 1994 105 113
68 Rasmussen T.R., Korsgaard J., Moller J.K., Sommer T., Kilian M.. Quantitative culture of bronchoalveolar lavage fluid in community-acquired lower respiratory tract infections Respir Med 95 2001 885 890
69 Ishida T., Hashimoto T., Arita M., Osawa M., Tachibana H., Nishioka M.. Efficacy of transthoracic needle aspiration in community-acquired pneumonia Intern Med 40 2001 873 877
70 Fine M.J., Auble T.E., Yealy D.M.. A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 1997 243 250
71 Marrie T.J., Lau C.Y., Wheeler S.L.. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-acquired pneumonia intervention trial assessing levofloxacin JAMA 283 2000 749 755
72 Lim W.S., Lewis S., Macfarlane J.T.. Severity prediction rules in community-acquired pneumonia: a validation study Thorax 55 2000 219 223
73 Capelastegui A., Espana P.P., Quintana J.M.. Validation of a predictive rule for the management of community-acquired pneumonia Eur Respir J 27 2006 151 157
74 Niederman M.S.. Eur Respir J 27 2006 9 11
75 Wunderink R.G., Waterer G.W.. Genetics of sepsis and pneumonia Curr Opin Crit Care 9 2003 384 389
76 Zasloff M.. Antimicrobial peptides of multicellular organisms Nature 415 2002 389 395
77 Brown K.L., Hancock R.E.. Cationic host defense (antimicrobial) peptides Curr Opin Immunol 18 2006 24 30
78 O'Neill L.A.. How Toll-like receptors signal: what we know and what we don't know Curr Opin Immunol 18 2006 3 9
79 Yeh W.C., Chen N.J.. Another Toll road Nature 424 2003 736 737
80 Panos R.J., Rubin J.S., Csaky K.G.. Keratinocyte-growth factor and hepatocyte growth factor/scatter factor and heparin-binding growth factor for alveolar type II cells in fibroblast-conditioned medium J Clin Invest 92 1993 969 977
81 Nayeri F., Millinger E., Nilsson I.. Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia Respir Med 96 2002 115 119